1. Home
  2. ABVE vs BRNS Comparison

ABVE vs BRNS Comparison

Compare ABVE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Above Food Ingredients Inc.

ABVE

Above Food Ingredients Inc.

HOLD

Current Price

$0.11

Market Cap

26.3M

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

N/A

Current Price

$0.65

Market Cap

24.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABVE
BRNS
Founded
2019
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
24.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ABVE
BRNS
Price
$0.11
$0.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
6.3M
17.7K
Earning Date
07-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.51
52 Week High
$6.56
$2.91

Technical Indicators

Market Signals
Indicator
ABVE
BRNS
Relative Strength Index (RSI) 28.37 50.97
Support Level N/A $0.65
Resistance Level $1.07 $0.75
Average True Range (ATR) 0.11 0.05
MACD -0.01 -0.00
Stochastic Oscillator 3.18 38.72

Price Performance

Historical Comparison
ABVE
BRNS

About ABVE Above Food Ingredients Inc.

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Share on Social Networks: